It took about two decades after micro and milli reactor technology has reached the production scale with significant production volumes. Now, curiosity and openness of chemical companies grow significantly to benefit from this technology’s potentials like access to new and better products, increased process performance and significantly better process safety.
In an interview with CHEManager, Edgardo Hernandez, President of Lilly Manufacturing, explains the strategy behind the ambitious investment project.
The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.
The EU Chemicals Strategy for Sustainability (CSS) highlights the shift to a hazard-centric approach in EU chemical regulation, emphasizing 'Substance of Concern' over risk-based measures.
A new approach is helping reduce waste, recover value, and deliver on sustainability goals.
The Validation 4.0 Guide provides a comprehensive approach to ensuring product quality and patient safety throughout a pharmaceutical product's lifecycle.
